US Broker Ratings

STERIS plc (STE) Stock Analysis: Uncovering a 5.76% Potential Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might want to turn their attention to STERIS plc (NYSE: STE), a leading player in the medical devices industry. With a market..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and a 3.75% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the healthcare sector, is making waves with a robust market cap of $30.85 billion. As a significant force in the..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Sector with 17% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical devices industry, offers a compelling investment case with its robust growth prospects and strategic positioning in the healthcare sector...

Natera, Inc. (NTRA) Stock Analysis: A Deep Dive into Its Diagnostic Leadership and Market Position

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, particularly in diagnostics and research, has been making significant waves with its innovative molecular testing services. With a market..

Masimo Corporation (MASI) Stock Analysis: Exploring a 28.57% Potential Upside in Healthcare Innovation

Healthcare investors keeping an eye on cutting-edge medical technology companies should consider Masimo Corporation (MASI), a prominent player in the medical devices industry. With a market capitalization of $7.65 billion,..

The Cooper Companies, Inc. (COO) Stock Analysis: Navigating the Healthcare Sector with a 6.51% Potential Upside

For individual investors seeking opportunities in the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) offers a compelling proposition. With a market capitalization of $15.55 billion, this American medical instruments..

Pfizer, Inc. (PFE) Stock Analysis: A 12.82% Potential Upside Amid Healthcare Sector Challenges

Pfizer, Inc. (PFE) stands as a stalwart in the healthcare sector, specifically within the drug manufacturing industry, where it has been a significant player for decades. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Look at Its Strong Revenue Growth and Strategic Position in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) is capturing the attention of investors with its innovative approach to treating obstructive sleep apnea (OSA). As a leader in the medical device industry,..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Upside Potential Amidst Mixed Analyst Sentiment

Investors eyeing Illumina, Inc. (NASDAQ: ILMN) find themselves at a crossroads, as the company’s stock presents a complex blend of growth potential and cautionary signals. With a market capitalization of..

Solventum Corporation (SOLV) Stock Analysis: Analyzing Growth Potential in the Healthcare Sector

Solventum Corporation (SOLV) stands out in the healthcare sector as a prominent player in the medical instruments and supplies industry. With a market capitalization of $14.79 billion, this Minnesota-based company..

iRhythm Technologies, Inc. (IRTC): Investor Outlook with a 16.98% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) has been steadily making waves in the healthcare sector, particularly within the medical devices industry. Based in San Francisco, California, iRhythm is a leading digital..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Potential 18% Upside Amid Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) presents a compelling investment opportunity in the healthcare sector, specifically within the biotechnology industry. Based in Dublin, Ireland, Jazz Pharmaceuticals is renowned for its innovative..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant with a Promising 4.3% Upside

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, is attracting attention from investors due to its robust market presence and promising growth potential. With a market capitalization..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Navigating a 13.3% Revenue Growth in the Healthcare Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leader in the healthcare sector specializing in diagnostics and research, has piqued investor interest with its impressive revenue growth and robust business model. Situated..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A High-Flying Biotech With 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector with its impressive revenue growth of 362%. This biopharmaceutical firm, headquartered in West Conshohocken, Pennsylvania, is focused on..

Bruker Corporation (BRKR) Stock Analysis: Navigating the Market with a $7.42 Billion Market Cap

Bruker Corporation (NASDAQ: BRKR) is a prominent player in the healthcare sector, operating within the medical devices industry. With a market capitalization of $7.42 billion, Bruker has established itself as..

Chemed Corp (CHE): Investor Outlook Reveals 30.75% Potential Upside Amid Strong Buy Ratings

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is gaining attention from investors with its impressive 30.75% potential upside and a unanimous buy rating from analysts. This..

Centene Corporation (CNC) Stock Analysis: Navigating Growth and Challenges in the Healthcare Sector

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans sector, offers a compelling yet complex investment narrative. The company’s stock is currently priced at $39.34, with a 52-week..

Ionis Pharmaceuticals (IONS): Analyst Consensus and Strategic Collaborations Signal Promising Growth Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has garnered significant attention in the biotechnology sector, not only for its innovative RNA-targeted medicines but also for its impressive market presence. With a market..

Vaxcyte, Inc. (PCVX) Stock Analysis: Uncovering an 85% Upside Potential in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to vaccine development. The company’s focus on conjugate and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds